Targeting STAT3 in castration-resistant prostate cancer: Galiellalactone as a direct inhibitor of STAT3 in prostate cancer cells.

被引：0
|
作者：
Hellsten, Rebecka
Don-Doncow, Nicholas
Escobar, Zilma
Johansson, Martin Hans
Kjellstrom, Sven
Garcia, Victor
Munoz, Eduardo
Sterner, Olov
Bjartell, Anders
机构：
[1] Lund Univ, Div Urol Canc, Malmo, Sweden
[2] Lund Univ, Ctr Anal & Synth, Lund, Sweden
[3] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden
[4] Univ Cordoba, Maimonides Inst Res Biomed Cordoba, Cordoba, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16065
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin
    Kjellstrom, Sven
    Garcia, Victor
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    Hellsten, Rebecka
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (23) : 15969 - 15978
  • [2] Targeting STAT3 in prostate cancer: Identification of STAT3 as a direct target of the fungal metabolite galiellalactone.
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    Hellsten, Rebecka
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Targeting the prostate cancer stem cell niche with the STAT3 inhibitor galiellalactone.
    Canesin, Giacomo
    Collins, Anne T.
    Hellsten, Rebecka
    Maitland, Norman J.
    Bjartell, Anders
    [J]. CANCER RESEARCH, 2018, 78 (16) : 45 - 46
  • [4] STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer
    Mohanty, Sambit K.
    Yagiz, Kader
    Pradhan, Dinesh
    Luthringer, Daniel J.
    Amin, Mahul B.
    Alkan, Serhan
    Cinar, Bekir
    [J]. ONCOTARGET, 2017, 8 (49) : 85997 - 86010
  • [5] STAT3 and STAT5a Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
    Mohanty, S. K.
    Yagiz, K.
    Cinar, B.
    Amin, M. B.
    Luthringer, D.
    Alkan, S.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 444A - 444A
  • [6] STAT3 and STAT5a Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
    Mohanty, S. K.
    Yagiz, K.
    Cinar, B.
    Amin, M. B.
    Luthringer, D.
    Alkan, S.
    [J]. MODERN PATHOLOGY, 2013, 26 : 444A - 444A
  • [7] STAT3 and STAT5a are potential therapeutic targets in castration-resistant prostate cancer
    Mohanty, Sambit K.
    Yagiz, Kader
    Luthringer, Luthringer
    Amin, Mahul B.
    Alkan, Serhan
    Cinar, Bekir
    [J]. CANCER RESEARCH, 2017, 77
  • [8] Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3
    Hu, Fei
    Zhao, Yu
    Yu, Yi
    Fang, Jue-min
    Cui, Ran
    Liu, Zhu-qing
    Guo, Xian-ling
    Xu, Qing
    [J]. CANCER LETTERS, 2018, 416 : 24 - 30
  • [9] Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
    Thaper, Daksh
    Vahid, Sepideh
    Kaur, Ramandeep
    Kumar, Sahil
    Nouruzi, Shaghayegh
    Bishop, Jennifer L.
    Johansson, Martin
    Zoubeidi, Amina
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [10] Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines
    Barton, BE
    Karras, JG
    Murphy, TF
    Barton, A
    Huang, HFS
    [J]. MOLECULAR CANCER THERAPEUTICS, 2004, 3 (01) : 11 - 20
12345